ARDS logo

Aridis Pharmaceuticals (ARDS) Cash From Investing

Annual CFI

-$82.00 K
+$448.00 K+84.53%

December 31, 2022

Summary

Performance

1-Year Change

+84.53%

3-Year Change

+52.87%

5-Year Change

+88.25%

15-Year Change

+88.25%

ARDS Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

57.3%
ARDS annual cash flow from investing activities is higher than 57.3% of companies in Healthcare sector

High & Low

All-time High

-$15.00 K

3-Year Low

-$530.00 K

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2022
ARDS previous annual earnings announcement was published on Dec 31, 2022

Next Annual Earnings Report Date

Feb 10, 2025
ARDS next annual earnings announcement is scheduled for Feb 10, 2025

OtherARDScash flowmetrics:

Annual CFF

$14.78 M
ARDS annual cash flow from financing activities is $14.78 million

Annual CFO

-$29.13 M
ARDS annual cash flow from operations is -$29.13 million

Annual FCF

-$29.21 M
ARDS annual free cash flow is -$29.21 million

Annual CAPEX

-
ARDS annual capital expenditures value is unknown

Quarterly CFI

$0.00
-$14.00 K-100.00%

September 30, 2023

Summary

Performance

3-Month Change

-100%

1-Year Change

-100%

3-Year Change

+100%

5-Year Change

+100%

ARDS Quarterly CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

68.16%
ARDS quarterly cash flow from investing activities is higher than 68.16% of companies in Healthcare sector

High & Low

All-time High

$242.00 K
ARDS quarterly cash flow from investing activities is currently -100.00% below its historical high of $242.00 thousand

3-Year Low

-$49.00 K

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2023
ARDS previous earnings announcement was published on Sep 30, 2023

Next Quarterly Earnings Report Date

Feb 10, 2025
ARDS next earnings announcement is scheduled for Feb 10, 2025

OtherARDScash flowmetrics:

Quarterly CFF

$999.00 K
ARDS quarterly cash flow from financing activities is $999.00 thousand

Quarterly CFO

-$983.00 K
ARDS quarterly cash flow from operations is -$983.00 thousand

Quarterly FCF

-$983.00 K
ARDS quarterly free cash flow is -$983.00 thousand

Quarterly CAPEX

-
ARDS quarterly capital expenditures value is unknown

TTM CFI

-$35.00 K
$0.000.00%

September 30, 2023

Summary

Performance

3-Month Change

0%

1-Year Change

0%

3-Year Change

+77.27%

5-Year Change

+79.89%

ARDS TTM CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

59.1%
ARDS TTM cash flow from investing activities is higher than 59.1% of companies in Healthcare sector

High & Low

All-time High

$10.00 K
ARDS TTM cash flow from investing activities is currently -450.00% below its historical high of $10.00 thousand

3-Year Low

-$530.00 K

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2023
ARDS previous earnings announcement was published on Sep 30, 2023

Next Quarterly Earnings Report Date

Feb 10, 2025
ARDS next earnings announcement is scheduled for Feb 10, 2025

OtherARDScash flowmetrics:

TTM CFF

$15.32 M
ARDS TTM cash flow from financing activities is $15.32 million

TTM CFO

-$17.89 M
ARDS TTM cash flow from operations is -$17.89 million

TTM FCF

-$17.93 M
ARDS TTM free cash flow is -$17.93 million

TTM CAPEX

-
ARDS TTM capital expenditures value is unknown

Cash From Investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

ARDS Cash From Investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+84.5%-100.0%0.0%
3 y3 years+52.9%+100.0%+77.3%
5 y5 years+88.3%+100.0%+79.9%

ARDS Cash From Investing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+84.5%-100.0%+100.0%-450.0%+93.4%
5 y5-yearat high+84.5%-100.0%+100.0%-450.0%+96.1%
alltimeall time-446.7%+95.1%-100.0%+100.0%-450.0%+97.9%

Aridis Pharmaceuticals Cash From Investing History

DateAnnualQuarterlyTTM
Sep 2023
-
$0.00(-100.0%)
-$35.00 K(0.0%)
Jun 2023
-
$14.00 K(>+9900.0%)
-$35.00 K(-42.6%)
Mar 2023
-
$0.00(-100.0%)
-$61.00 K(-25.6%)
Dec 2022
-$82.00 K(-84.5%)
-$49.00 K(<-9900.0%)
-$82.00 K(-920.0%)
Sep 2022
-
$0.00(-100.0%)
$10.00 K(-109.6%)
Jun 2022
-
-$12.00 K(-42.9%)
-$104.00 K(-51.9%)
Mar 2022
-
-$21.00 K(-148.8%)
-$216.00 K(-59.2%)
Dec 2021
-$530.00 K(+44.4%)
$43.00 K(-137.7%)
-$530.00 K(-41.6%)
Sep 2021
-
-$114.00 K(-8.1%)
-$907.00 K(+12.1%)
Jun 2021
-
-$124.00 K(-63.0%)
-$809.00 K(+17.4%)
Mar 2021
-
-$335.00 K(+0.3%)
-$689.00 K(+87.7%)
Dec 2020
-$367.00 K
-$334.00 K(+1987.5%)
-$367.00 K(+138.3%)
Sep 2020
-
-$16.00 K(+300.0%)
-$154.00 K(-6.1%)
Jun 2020
-
-$4000.00(-69.2%)
-$164.00 K(+144.8%)
DateAnnualQuarterlyTTM
Mar 2020
-
-$13.00 K(-89.3%)
-$67.00 K(-61.5%)
Dec 2019
-$174.00 K(-89.6%)
-$121.00 K(+365.4%)
-$174.00 K(-83.5%)
Sep 2019
-
-$26.00 K(-128.0%)
-$1.05 M(+34.1%)
Jun 2019
-
$93.00 K(-177.5%)
-$785.00 K(-48.5%)
Mar 2019
-
-$120.00 K(-88.0%)
-$1.52 M(-9.1%)
Dec 2018
-$1.68 M(+140.3%)
-$1.00 M(-513.2%)
-$1.68 M(+73.8%)
Sep 2018
-
$242.00 K(-137.4%)
-$965.00 K(-40.3%)
Jun 2018
-
-$647.00 K(+137.9%)
-$1.62 M(+66.7%)
Mar 2018
-
-$272.00 K(-5.6%)
-$970.00 K(+39.0%)
Dec 2017
-$698.00 K(+4553.3%)
-$288.00 K(-29.8%)
-$698.00 K(+70.2%)
Sep 2017
-
-$410.00 K(<-9900.0%)
-$410.00 K(<-9900.0%)
Jun 2017
-
$0.00(0.0%)
$0.00(0.0%)
Mar 2017
-
$0.00
$0.00
Dec 2016
-$15.00 K
-
-

FAQ

  • What is Aridis Pharmaceuticals annual cash flow from investing activities?
  • What is the all time high annual CFI for Aridis Pharmaceuticals?
  • What is Aridis Pharmaceuticals annual CFI year-on-year change?
  • What is Aridis Pharmaceuticals quarterly cash flow from investing activities?
  • What is the all time high quarterly CFI for Aridis Pharmaceuticals?
  • What is Aridis Pharmaceuticals quarterly CFI year-on-year change?
  • What is Aridis Pharmaceuticals TTM cash flow from investing activities?
  • What is the all time high TTM CFI for Aridis Pharmaceuticals?
  • What is Aridis Pharmaceuticals TTM CFI year-on-year change?

What is Aridis Pharmaceuticals annual cash flow from investing activities?

The current annual CFI of ARDS is -$82.00 K

What is the all time high annual CFI for Aridis Pharmaceuticals?

Aridis Pharmaceuticals all-time high annual cash flow from investing activities is -$15.00 K

What is Aridis Pharmaceuticals annual CFI year-on-year change?

Over the past year, ARDS annual cash flow from investing activities has changed by +$448.00 K (+84.53%)

What is Aridis Pharmaceuticals quarterly cash flow from investing activities?

The current quarterly CFI of ARDS is $0.00

What is the all time high quarterly CFI for Aridis Pharmaceuticals?

Aridis Pharmaceuticals all-time high quarterly cash flow from investing activities is $242.00 K

What is Aridis Pharmaceuticals quarterly CFI year-on-year change?

Over the past year, ARDS quarterly cash flow from investing activities has changed by -$14.00 K (-100.00%)

What is Aridis Pharmaceuticals TTM cash flow from investing activities?

The current TTM CFI of ARDS is -$35.00 K

What is the all time high TTM CFI for Aridis Pharmaceuticals?

Aridis Pharmaceuticals all-time high TTM cash flow from investing activities is $10.00 K

What is Aridis Pharmaceuticals TTM CFI year-on-year change?

Over the past year, ARDS TTM cash flow from investing activities has changed by $0.00 (0.00%)